MBAI Announces Yale-Affiliated Provider as Beta Customer Today, MedBright AI Investments Inc. (Ticker: MBAI.c or MBAIF for US investors) announced that CareMEDICA will be implementing the beta version of MedMatrix, MBAI's cutting-edge AI-driven data and analytics platform. This strategic move marks a significant step forward in the integration of artificial intelligence into the healthcare landscape.
CareMEDICA, recognized for its longstanding commitment to providing exceptional primary care services in Connecticut and South Florida, has chosen to leverage the power of MedMatrix to enhance its clinical operations. The clinic group, with affiliations to both Yale University School of Medicine and Quinnipiac University Medical Program, has a reputation for delivering personalized healthcare that goes beyond conventional standards.
MedMatrix, as an AI-powered data analytics platform, excels in evaluating and analyzing crucial aspects of healthcare facilities, ranging from patient needs and resource matching to revenue cycle management, patient demographics, facility geography, and competition. By leveraging advanced AI and data analytics capabilities, MedMatrix collaborates with healthcare professionals to optimize these critical areas, leading to more efficient clinic operations and improved patient outcomes.
Dr. Fausto Petruzziello, Medical Director of CareMEDICA, expressed enthusiasm about the partnership, stating, “It makes natural sense to leverage AI as a tool to help improve clinical efficiency, as it can process data much faster than the human mind. I’m looking forward to seeing the positive outcomes that MedMatrix can provide.”
This announcement follows last week’s revelation where MedBright introduced the first beta customer for MedMatrix, further solidifying the platform's presence and potential impact on the healthcare industry.
Full article here: https://www.globenewswire.com/news-release/2023/12/14/2796208/0/en/MedBright-AI-Announces-CareMEDICA-a-Yale-University-School-of-Medicine-Affiliated-Clinic-Group-as-Beta-Customer-for-MedMatrix-the-AI-Driven-Data-and-Analytics-Platform.html
Posted on behalf of MedBright AI Investments Inc.